about us
CEO Message
Leadership
Company Overview
History
Investors
technology
PHENOTYPIC SCREENING
TARGET ID/MOA
PROTEOMICS/BIOMARKER
pDOS
SEOUL-FLUOR
FITGE/TS-FITGE
Molecular Splitter for TPU
R&D
Research Interest
Disease Area
Pipeline
order
Bioprobe
media
Press
News
Gallery
Reference
contact us
Location
Tel. +82-2-887-9090
media
spark biopharma
스파크바이오파마, AACR에서 초청연사로 STING 조절 면역항암제 연구성과 발표
작성자 :
관리자
등록일 : 2022.03.18
조회수
969
링크 :
http://www.biospectator.com/view/news_view.php?varAtcId=15814
목록